Cell therapy for multiple sclerosis patients: Closer than ever?
Posted: July 28, 2014 at 8:41 am
Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient's own cells.
For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they developed an accelerated protocol to induce these stem cells into becoming oligodendrocytes, the myelin-forming cells of the central nervous system implicated in multiple sclerosis and many other diseases.
Existing protocols for producing oligodendrocytes had taken almost half a year to produce, limiting the ability of researchers to conduct their research. This study has cut that time approximately in half, making the ability to utilize these cells in research much more feasible.
Stem cell lines and oligodendrocytes allow researchers to "turn back the clock" and observe how multiple sclerosis develops and progresses, potentially revealing the onset of the disease at a cellular level long before any symptoms are displayed. The improved protocol for deriving oligodendrocyte cells will also provide a platform for disease modeling, drug screening, and for replacing the damaged cells in the brain with healthy cells generated using this method.
"We are so close to finding new treatments and even cures for MS. The enhanced ability to derive the cells implicated in the disease will undoubtedly accelerate research for MS and many other diseases," said Susan L. Solomon, NYSCF Chief Executive Officer.
"We believe that this protocol will help the MS field and the larger scientific community to better understand human oligodendrocyte biology and the process of myelination. This is the first step towards very exciting studies: the ability to generate human oligodendrocytes in large amounts will serve as an unprecedented tool for developing remyelinating strategies and the study of patient-specific cells may shed light on intrinsic pathogenic mechanisms that lead to progressive MS." said Dr. Valentina Fossati, NYSCF -- Helmsley Investigator and senior author on the paper.
In multiple sclerosis, the protective covering of axons, called myelin, becomes damaged and lost. In this study, the scientists not only improved the protocol for making the myelin-forming cells but they showed that the oligodendrocytes derived from the skin of primary progressive patients are functional, and therefore able to form their own myelin when put into a mouse model. This is an initial step towards developing future autologous cell transplantation therapies in multiple sclerosis patients
This important advance opens up critical new avenues of research to study multiple sclerosis and other diseases. Oligodendrocytes are implicated in many different disorders, therefore this research not only moves multiple sclerosis research forward, it allows NYSCF and other scientists the ability to study all demyelinating and central nervous system disorders.
"Oligodendrocytes are increasingly recognized as having an absolutely essential role in the function of the normal nervous system, as well as in the setting of neurodegenerative diseases,such as multiple sclerosis. The new work from the NYSCF Research Institute will help to improve our understanding of these important cells. In addition, being able to generate large numbers of patient-specific oligodendrocytes will support both cell transplantation therapeutics for demyelinating diseases and the identification of new classes of drugs to treat such disorders," said Dr. Lee Rubin, NYSCF Scientific Advisor and Director of Translational Medicine at the Harvard Stem Cell Institute.
Multiple sclerosis is a chronic, inflammatory, demyelinating disease of the central nervous system, distinguished by recurrent episodes of demyelination and the consequent neurological symptoms. Primary progressive multiple sclerosis is the most severe form of multiple sclerosis, characterized by a steady neurological decline from the onset of the disease. Currently, there are no effective treatments or cures for primary progressive multiple sclerosis and treatments relies merely on symptom management.
View post:
Cell therapy for multiple sclerosis patients: Closer than ever?
- Most Common Multiple Sclerosis Treatments - March 21st, 2018
- Multiple Sclerosis Market in the US 2015-2019 - Research ... - August 1st, 2015
- Multiple Sclerosis: Treatment and Global Market - Research ... - July 1st, 2015
- Multiple Sclerosis Research: natalizumab has a ... - June 14th, 2015
- New Multiple Sclerosis Circulation Theory Links Posture ... - June 10th, 2015
- Stem cell research benefits Houston woman with multiple sclerosis - April 6th, 2015
- Stem cell research benefits area woman with multiple sclerosis - April 6th, 2015
- Is a loophole in stem cell law helping new therapy to thrive, or allowing dubious science? - April 4th, 2015
- Multiple sclerosis can be scary, but a new treatment holds promise - April 1st, 2015
- Hoping for a cure - February 11th, 2015
- Jan. 30: Sacrificing health, multiple sclerosis research, sunscreen in winter - February 2nd, 2015
- This Could Be Game-Changing News in the Battle Against Multiple Sclerosis - February 2nd, 2015
- Latest Sports SEE MORE - January 30th, 2015
- Ottawa Hospital leads Canadian clinial trial on stem cell therapy in MS patients - January 29th, 2015
- Early Study Says Stem Cells May Reverse Multiple Sclerosis Disability - January 22nd, 2015
- Jan. 21: Bisphenol A research, multiple sclerosis treatment - January 22nd, 2015
- Airdrian says costly treatment a scam - January 21st, 2015
- Saskatoon woman snared in alleged fraudulent MS trial held in India - January 20th, 2015
- The 'impossible' dream: City firm's MS claims not medically possible, says top researcher - January 18th, 2015
- Sask. MS patient recounts good experience with research firm now under question - January 16th, 2015
- City man who ran stem-cell trial for MS patients fabricated credentials, overstated results - January 15th, 2015
- Fallout from fake credentials - January 15th, 2015
- U of W cancels proposal for joint research study - January 15th, 2015
- City man who ran stem-cell trial for MS patients fabricated credentials, overstated treatment results - January 14th, 2015
- News & Events - December 30th, 2014
- One MS patient's 'starting line' for stem cell therapy - October 14th, 2014
- First Spanish-Filipino biotech firm introduced - October 3rd, 2014
- Cambridge scientist Dr Su Metcalfe awarded 150k for ground-breaking MS trials - October 2nd, 2014
- New Mount Sinai Research Indicates Cells From Placentas are Safe for Patients with Multiple Sclerosis - September 29th, 2014
- Vaccine Against MS Being Developed at Baylor Institute for ... - September 25th, 2014
- Stem cells use 'first aid kits' to repair damage - September 18th, 2014
- MS stem-cell breakthrough led by Italians - September 9th, 2014
- Could Reprogrammed Cells Fight 'Untreatable' Diseases? - August 28th, 2014
- Ore. man gets results from stem cell transplant - July 29th, 2014
- Scientists 1 step closer to cell therapy for multiple ... - July 24th, 2014
- Monday, July 21, 2014 12:00 am - July 21st, 2014
- Stem cell researcher to use national prize to treat brain conditions - June 3rd, 2014
- Updates on Stem Cell Research and MS - Video - June 1st, 2014
- Stem cell therapy shows promise for multiple sclerosis - May 16th, 2014
- Mice with multiple sclerosis-like condition walk again after human stem cell treatment - May 16th, 2014
- Stem Cells Reverse MS-Like Illness in Mice - May 16th, 2014
- Stem Cell Therapy Shows Promise for MS in Mouse Model - May 16th, 2014
- Mice With MS-Like Condition Walk Again After Human Stem Cell Treatment - May 16th, 2014
- Tisch MS Research Center of New York Exceeds $300K Crowdfunding Target for FDA-Approved Stem Cell Trial - April 15th, 2014
- Whats Going Around: Multiple Sclerosis Research - April 8th, 2014
- Umbilical Cord Stem Cell Therapy Clinical Trial for Multiple Sclerosis Gets Green Light - April 3rd, 2014
- The Multiple Sclerosis Association of America Publishes 2014 MS Research Update - February 20th, 2014
- Deep TCR sequencing reveals extensive renewal of the T cell repertoire following autologous stem cell transplant in MS - February 19th, 2014
- Richard M. Cohen -- Stem cell cultivation - Video - January 28th, 2014
- MS patient to take part in pioneering experiment - January 20th, 2014
- Research in Multiple Sclerosis - January 14th, 2014
- Preferable treatment for MS found in allogenic bone marrow stem cells - December 19th, 2013
- Vitamin D may help fight MS: study - December 12th, 2013
- Multiple sclerosis research - Wikipedia, the free encyclopedia - November 7th, 2013
- Multiple Sclerosis: Hope Through Research: National Institute of ... - November 1st, 2013
- BrainStorm to Initiate Study for Multiple Sclerosis at Hadassah Medical Center - October 15th, 2013
- Bike 150 miles in two days to raise money for Multiple Sclerosis research - August 19th, 2013
- Stem cell spine injections for MS - trial approved - August 17th, 2013
- FDA Approves Stem Cell Clinical Trial For Multiple Sclerosis - August 15th, 2013
- Transatlantic partnership to tackle neurodegenerative disease - July 19th, 2013
- Multiple Sclerosis Drugs Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market ... - July 15th, 2013
- Revolution starts at bioscience campus - July 1st, 2013
- Advanced Sclerosis research at AIIMS soon - May 26th, 2013
- Stanford: treatment delays multiple sclerosis onset in mice - May 14th, 2013
- Turning Stem Cells Into Brain Cells To Cure Multiple Sclerosis And Cerebral Palsy - April 15th, 2013
- Major advance in understanding risky but effective multiple sclerosis treatment - March 27th, 2013
- New skin cell treatment offers new hope to MS patients - February 10th, 2013
- Cells forged from human skin show promise in treating MS, myelin disorders - February 7th, 2013
- Cells forged from human skin show promise in treating multiple sclerosis, myelin disorders - February 7th, 2013
- Birax grants NIS 25m for Israel-UK stem cell projects - January 22nd, 2013
- Multiple sclerosis drug may one day treat colorectal cancer - January 10th, 2013
- Stem Cell Showdown: Celltex vs. the FDA - January 4th, 2013
- ACADIA Pharmaceuticals to Receive Funding from Fast Forward and EMD Serono for Multiple Sclerosis Program - December 21st, 2012
- EMD Serono, Inc. and Fast Forward, LLC Announce Recipients of Funding for Multiple Sclerosis Research - December 21st, 2012
- Ballenger Trust Selects the Myelin Repair Foundation to Advance Myelin Repair Therapeutic Development for Multiple ... - December 18th, 2012
- Christchurch neurologist part of MS trial - December 17th, 2012
- Therafit Gym Multiple Sclerosis Jody MS (stem cell trial).wmv - Video - November 20th, 2012
- jodyMSvideo2012 0001 - Video - November 14th, 2012
- Stem Cell Transplants May Show Promise for Multiple Sclerosis - October 12th, 2012
- StemGenexâ„¢ on Adult Stem Cell-Based Therapy for Multiple Sclerosis - October 10th, 2012